Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD

Study results support Owlstone Medical’s development of breath-based diagnostic and prognostic tests for liver disease Data validates Owlstone Medical’s EVOC® Probe strategy for breath-based diagnostic test development Results published in Clinical and Translational Gastroenterology Cambridge, UK, September 22 2020: Owlstone Medical, the global leader in Breath Biopsy® for applications in early ...

22 Sep 20

Get all the latest news and discoveries direct to your inbox

Sign up to our newsletter